Search Articles and Web Sources

Search Results

In this project

Solod: Go without GC with compilation to C

https://sudonull.com/solod-go-without-gc-with-compilation-to-c

Solod is a subset of Go with manual memory management, compiles to C11. Benchmarks, features, integration with C. Ideal for systems programming. Learn more.

AsmX Raptor: Native assembler and strict typing in system programming

https://sudonull.com/asmx-raptor-native-assembler-and-strict-typing-in-system-programming

AsmX Raptor integrates assembler into the compiler's AST, offering unprecedented control and security for systems developers. Learn about the new compilation pipeline, evolution of the type system, and support for version-independent Linux kernel modules.

Renga API and AI Agents for BIM

https://sudonull.com/renga-api-and-ai-agents-for-bim

Integrate AI with Renga API via COM and Python. Automate plugins, STDL families. Comparison with Revit, code examples. Start development without compilation.

KITE: language in C for Termux and Android

https://sudonull.com/kite-language-in-c-for-termux-and-android

Learn how to implement the KITE language interpreter in C: lexer, parser, AST, refcounting. Compilation in Termux, OOP, closures. Sources are open — study and improve them.

Dart backend: benchmarks and memory issues

https://sudonull.com/dart-backend-benchmarks-and-memory-issues

Dart vs Node.js benchmarks: latency 9.5s, memory not returned in K8s. Why migration failed, ecosystem and GC for Flutter. Read raw results.

From other projects

FDA approval of combination immunotherapy for bladder cancer: durvalumab + BCG

https://ymaho.com/fda-approval-of-combination-immunotherapy-for-bladder-cancer-durvalumab-bcg

FDA approved durvalumab with BCG for high-risk NMIBC. POTOMAC data: 32% risk reduction. Analysis of efficacy, toxicity, and consequences of BCG shortage. Learn more.

Orphan status of combination for lung cancer treatment: new EMA approach

https://ymaho.com/orphan-status-of-combination-for-lung-cancer-treatment-new-ema-approach

European Commission granted orphan status to Zepzelca combination with atezolizumab for lung cancer. Learn how EMA reform changes rules for SCLC and who benefits from this decision. Detailed analysis.

New drug combination for lung cancer therapy: European approval

https://ymaho.com/new-drug-combination-for-lung-cancer-therapy-european-approval

European Commission approved Zepzelca and atezolizumab combination for aggressive lung cancer. 27% reduction in risk of death. Learn details about the new standard of therapy.

FDA approved Differin Epiduo over-the-counter: combination gel for acne

https://ymaho.com/fda-approved-differin-epiduo-over-the-counter-combination-gel-for-acne

Learn how FDA approved the first over-the-counter gel Differin Epiduo (adapalene+benzoyl peroxide) for treating acne in adolescents and adults. Price, benefits, risks — read in the analysis.

FDA approved Imfinzi: first immunotherapeutic combination for bladder cancer

https://ymaho.com/fda-approved-imfinzi-first-immunotherapeutic-combination-for-bladder-cancer

FDA approved Imfinzi (durvalumab) + BCG for high-risk non-muscle-invasive bladder cancer. 32% reduction in recurrence risk. Learn about the breakthrough in oncourology.

DeepDrug AI model predicts drug interactions: 12 thousand dangerous combinations

https://ymaho.com/deepdrug-ai-model-predicts-drug-interactions-12-thousand-dangerous-combinations

DeepDrug found 12 thousand dangerous drug combinations. How AI is changing pharmacology and why it threatens pharma giants? Detailed analysis.

Hepatitis C cocktail: cure in 7–8 weeks

https://ymaho.com/hepatitis-c-cocktail-cure-in-7-8-weeks

The combination of bemnifosbuvir and ruzasvir reduces the treatment course for hepatitis C from 12 to 7–8 weeks. Learn about trial results and benefits of the new regimen.

Scandinavian protocol: magnesium baths and forest saunas

https://ymaho.com/scandinavian-protocol-magnesium-baths-and-forest-saunas

How the combination of floating with magnesium and forest sauna reduces cortisol by 32% and changes the wellness market. Find out the session price and risks of the new trend.

KRAS G12C colorectal cancer: sotorasib + panitumumab breakthrough

https://ymaho.com/kras-g12c-colorectal-cancer-sotorasib-panitumumab-breakthrough

CodeBreak300 phase 3: Lumakras and Vectibix combination increased progression-free survival by 3 months. Treatment of KRAS G12C metastases approved. How dual blockade breaks 40-year resistance.

Green buckwheat and fermented chia seeds: superfoods of summer 2026

https://ymaho.com/green-buckwheat-and-fermented-chia-seeds-superfoods-of-summer-2026

University of Toronto study: the combination increases magnesium bioavailability by 71% and reduces sugar cravings by 40%. Who benefits and who loses? Read the analysis.